Contrasting actions of prolonged mitogen-activated protein kinase activation on cell survival

Biochem Biophys Res Commun. 2006 Jun 30;345(2):843-50. doi: 10.1016/j.bbrc.2006.04.161. Epub 2006 May 5.

Abstract

Activation of the ERK mitogen-activated protein kinase pathway has been implicated in pro-survival and cellular protective mechanisms, so that chronic ERK activation may be a useful therapeutic strategy. Here, we further explored the consequences of prolonged ERK activation following expression of constitutively active form of MEK, MEK-EE, in cardiac myocytes. We confirmed that chronic MEK-EE overexpression halved myocyte death following glucose deprivation, but surprisingly this was not associated with preserved intracellular ATP levels. Whilst activities of a number of antioxidant enzymes were not altered upon MEK-EE expression, paradoxically Cu/Zn superoxide dismutase activity was almost halved upon MEK-EE expression. When we then exposed myocytes to the superoxide generator menadione, we observed significantly higher death of MEK-EE expressing myocytes. Pre-incubation with U0126 inhibited menadione-induced death. Our results are the first to show that MEK-ERK signalling can act to increase or decrease cell survival, the outcome depending on the form of stress stimulus encountered.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Animals
  • Antioxidants / pharmacology
  • Butadienes / pharmacology
  • Cell Survival / physiology
  • Enzyme Activation
  • Enzyme Inhibitors / pharmacology
  • Gene Expression Regulation
  • Glucose / deficiency
  • Glucose / metabolism
  • Glutamic Acid / genetics
  • Mitogen-Activated Protein Kinases / metabolism
  • Mitogen-Activated Protein Kinases / physiology*
  • Myocytes, Cardiac / cytology*
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / enzymology
  • Nitriles / pharmacology
  • Point Mutation
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction
  • Superoxide Dismutase / metabolism
  • Time Factors
  • Vitamin K 3 / pharmacology

Substances

  • Antioxidants
  • Butadienes
  • Enzyme Inhibitors
  • Nitriles
  • U 0126
  • Glutamic Acid
  • Vitamin K 3
  • Adenosine Triphosphate
  • Superoxide Dismutase
  • Mitogen-Activated Protein Kinases
  • Glucose